Getein1100 Immunofluorescence Quantitative Analyzer is an advanced on-site diagnostic analyzer, intended to deliver accurate testing results in minutes just from 3-4 drops of human specimens. Thanks to its simple design and small footprint, Getein1100 becomes an ideal system for emergency department, intensive care units, or anywhere treatment and research needed at the point of care.

Test Items

Cardiac Marker	cTnI, TnT, BNP, NT-proBNP, H-FABP, CK-MB, CK-MB/cTnI, CK-MB/cTnI/Myo, CK-MB/cTnI/H-FABP
Coagulation Marker	D-Dimer
Inflammation	hs-CRP+CRP, PCT, PCT/CRP, SAA/CRP, SAA, IL-6
Diabetes	HbA1c
Renal Function	CysC, mAlb, NGAL, β2-MG
Metabolic Marker	25-OH-VD
Thyroid Function	TSH, T3, T4, fT3, fT4
Tumor Markers	tPSA, fPSA, AFP, CEA
Reproduction/Fertility	HCG+β, FSH, LH, PRL, AMH, Prog
Infectious Disease	Anti-HCV, Anti-TP, Anti-HIV, SARS-CoV-2 Neutralizing Antibody, HBsAg, Anti-HBs, Dengue NS1 Ag, 2019-nCoV IgM/IgG, SARS-CoV-2 Antigen, H. pylori
Specific Protein and Rheumatism	RF, ASO
Others	Ferritin, Total IgE

Getein Biotech, Inc. (SSE stock code:603387) is a fully integrated in vitro diagnostic company that develops, manufactures and distributes analytical medical devices as well as a broad range of innovative diagnostic test kits, dedicated to making diagnostics more accessible, more affordable, and more equitable for humanity. Since its foundation in 2002, Getein Biotech has launched 10 advanced technology platforms and possesses more than 200 independent intellectual property products. Headquartered in Nanjing, China, Getein Biotech has grown steadily and rapidly in North and South America, Europe, Africa, and the Asia-Pacific region. At present, the products and services of Getein Biotech are available in over 140 countries.